packageDabrafenib

dabrafenib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dabrafenib is a BRAF protein kinase inhibitor used to treat melanoma, including metastatic melanoma, and other cancers such as non-small-cell lung carcinoma and glioma. It is an approved cancer medicine, authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q3011604 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dabrafenib
ATC codes:L01EC02
DrugBank:DB08912
PubChem CID:44462760
ChEBI:75045
Wikidata:Q3011604
formula:C23H20F3N5O2S2
molar mass:519.56 g/mol (PubChem CID 44462760)
logP:4.8 (Drugs.Common 25.09, not verified)

Metabolites

HydroxyDabrafenibhydroxy-dabrafenib535.559 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
HydroxyDabrafenibmetabolite: hydroxy-dabrafenib